Paper published in a journal (Scientific congresses and symposiums)
Effect of single annual infusion of zoledronic acid on bone turnover markers versus daily oral risedronate in patients with glucocorticoid-induced osteoporosis
Sambrook, P.; Reid, D.; Devogelaer, Jean-Pierre et al.
2009In Osteoporosis International, 20 (Suppl.1), p. 128-129
Peer Reviewed verified by ORBi
 

Files


Full Text
P361.pdf
Publisher postprint (282.98 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Public health, health care sciences & services
Author, co-author :
Sambrook, P.
Reid, D.
Devogelaer, Jean-Pierre
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Saag, K.
Roux, Christian
Papanastasiou, P.
Maylandt, K.
Fashola, T.
Mesenbrink, P.
Language :
English
Title :
Effect of single annual infusion of zoledronic acid on bone turnover markers versus daily oral risedronate in patients with glucocorticoid-induced osteoporosis
Publication date :
April 2009
Event name :
Ninth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
Event organizer :
ECCEO Congresses Zrt. and the International Osteoporosis Foundation
Event place :
Athens, Greece
Event date :
du 18 mars 2009 au 21 mars 2009
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
20
Issue :
Suppl.1
Pages :
S128-129
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 13 September 2010

Statistics


Number of views
57 (5 by ULiège)
Number of downloads
1 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi